Mobile low-threshold buprenorphine integrated with infectious disease services

Rosecrans, Amanda; Harris, Robert S.; Saxton, Ronald; Cotterell, Margaret; Zoltick, Meredith; Willman, Catherine; Blackwell, Ingrid; Bell, Joy; Hayes, Darryl; Weir, Brian W.; Sherman, Susan G.; Lucas, Gregory M.; Greenbaum, Adena; Page, Kathleen R.

doi:10.1016/j.jsat.2021.108553

Cited by 23 publications

(13 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 1 , 3 , 40 Among MHC programs, a study which aimed to screen and link patients to external treatment reported that 63.0% (17/27) were linked, but the MHC did not directly prescribe medication, provide treatment, or follow-up; and a study prescribing medication reported that 32.8% (19/58) initiated treatment. 12 , 29 There was particularly encouraging uptake among PWID and uninsured individuals. Lack of insurance and IDU are established barriers to downstream uptake of treatment following diagnosis.…”

Section: Discussionmentioning

confidence: 99%

“…HCV screening and treatment is rarely a provided service in MHCs and when MHCs have been successful in screening patients for HCV and linking them to care, the MHC’s utility as a vehicle to follow-up or provide treatment is unexplored, particularly with primary focus on HCV and uninsured populations at-risk of HCV. 12 , 13 , 29 In the face of challenges, the durability of MHCs relies on research and novel approaches to care to mitigate barriers and optimize their potential to serve the community.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study

Rennert,

Howard,

Kickham

et al. 2024

The Lancet Regional Health - Americas

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study

Rennert,

Howard,

Kickham

et al. 2024

The Lancet Regional Health - Americas

View full text Add to dashboard Cite

“…Conversely, there may be opportunities to learn from the few “bright spots” (for example, Alaska, Kansas, Maryland, Vermont, and Washington, D.C.) where parity or near-parity was attained. For example, Maryland undertook substantial initiatives to expand buprenorphine access in Baltimore, including the Baltimore Buprenorphine Initiative, 14 expansion of buprenorphine in methadone opioid treatment programs, and integration of buprenorphine into formerly “drug-free” 15 , 16 and syringe service 17 programs.…”

Section: Discussionmentioning

confidence: 99%

Racial And Ethnic Disparities In Buprenorphine Receipt Among Medicare Beneficiaries, 2015–19

Miles,

Treitler,

Lloyd

et al. 2023

Health Affairs

View full text Add to dashboard Cite

We examined Medicare Part D claims from the period 2015–19 to identify state and national racial and ethnic disparities in buprenorphine receipt among Medicare disability beneficiaries with diagnosed opioid use disorder or opioid overdose. Racial and ethnic disparities in buprenorphine use remained persistently high during the study period, especially for Black beneficiaries, suggesting the need for targeted interventions and policies.

show abstract

“…In addition, making safe space for PWUD to fill roles on local planning boards, advisory committees, and funding review boards is crucial. Given the new Drug Enforcement Agency allowance for a mobile component, 17 and increasing availability of outcomes associated with low-threshold mobile buprenorphine programs, [18][19][20] a pilot study of low-threshold MOUD services, informed by PWUD, is a logical next step.…”

Section: Recommendations For Research Policy and Practicementioning

confidence: 99%

Perceptions and Experiences With Evidence-based Treatments Among People Who Use Opioids

et al. 2022

View full text Add to dashboard Cite

Objectives: Even where treatment is available, people who use drugs (PWUD) may not seek help. Few published studies examine beliefs, experiences, and perceptions of evidence-based treatment among PWUD who are not actively engaged in care. This study aimed to explore the experiences of PWUD in considering or accessing treatment and gauge receptiveness to low-threshold treatment models. Methods: A purposeful sample of participants actively using opioids and with previous interest in or experience with treatment was recruited from a harm reduction program in Chicago. Semistructured interviews were conducted to explore key phenomena while allowing for unanticipated themes. The instrument included questions about historical drug use, treatment experience, and perceptions of how to improve treatment access and services. Private interviews were audio recorded, transcribed, and double coded by 2 analysts. Queries of coded data were analyzed using issue-focused analysis to identify themes. Results: The sample (N = 40) approximated groups at highest risk of fatal overdose in Chicago, with more than 80% between the ages of 45 to 64 years, 65% African American, and 62% male identified. The majority had prior treatment experience, although all resumed use after completing or leaving treatment. The most prevalent barriers to treatment included structural barriers related to social determinants, lack of readiness for abstinence, burdensome intake procedures, and regulatory/programmatic requirements. Most participants expressed interest in low-threshold treatment. Conclusions: Existing treatment barriers may be addressed by shifting to lower-threshold intake processes and/or outreach-based delivery of opioid agonist treatment. Engaging PWUD in efforts to create lowerthreshold treatment programs is necessary to ensure that needs are met.

show abstract

Mobile low-threshold buprenorphine integrated with infectious disease services

Cited by 23 publications

References 24 publications

Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study

Implementation of a mobile health clinic framework for Hepatitis C virus screening and treatment: a descriptive study

Racial And Ethnic Disparities In Buprenorphine Receipt Among Medicare Beneficiaries, 2015–19

Perceptions and Experiences With Evidence-based Treatments Among People Who Use Opioids

Contact Info

Product

Resources

About